3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Melanoma
9
Pancreatic Neoplasms
7
Glioblastoma
7
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
4
Triple Negative Breast Neoplasms
3
Ovarian Neoplasms
3
Neoplasms
3
Lung Neoplasms
3
Colonic Neoplasms
3
Urinary Bladder Neoplasms
2
Prostatic Neoplasms
2
Osteosarcoma
2
Myelodysplastic Syndromes
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Glioma
2
Fibrolamellar hepatocellular carcinoma
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Merkel Cell
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urologic Neoplasms
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Interventions
Cisplatin
27
pembrolizumab
21
Brachytherapy
16
Radiotherapy
14
Carboplatin
10
Radiation
8
Paclitaxel
8
Platinum
7
1,2-diaminocyclohexaneplatinum II citrate
7
Topotecan
6
fludarabine
5
atezolizumab
5
Magnetic Resonance Spectroscopy
5
Fluorodeoxyglucose F18
5
Cyclophosphamide
5
Bevacizumab
5
durvalumab
4
Nivolumab
4
Gemcitabine
4
tremelimumab
3
temsirolimus
3
human papillomavirus vaccine, L1 type 16, 18
3
aldesleukin
3
Radiotherapy, Intensity-Modulated
3
Papillomavirus Vaccines
3
Ipilimumab
3
Interleukin-2
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Docetaxel
3
Biopsy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Uterine Cervical Neoplasms
×
poly ICLC
×
Clear all
NCT04116320
2025-07-14
AM-003
University of Virginia
Phase 1
Terminated
5 enrolled